Yalçın, C. Et Al. 2022. Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.14, no.1 .

Yalçın, C., Özkalemkaş, F., Özkocaman, V., Ersal, T., Pınar, İ. E., Orhan, B., ... Candar, Ö.(2022). Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.14, no.1.

Yalçın, Cumali Et Al. "Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia," MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.14, no.1, 2022

Yalçın, Cumali Et Al. "Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia." MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.14, no.1, 2022

Yalçın, C. Et Al. (2022) . "Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia." MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES , vol.14, no.1.

@article{article, author={Cumali Yalçın Et Al. }, title={Evaluation of Using Empiric Glycopeptides in Accordance with the IDSA Guidelines in Hematologic Malignancy Patients with Febrile Neutropenia}, journal={MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES}, year=2022}